Comparison of the antimicrobial activities of gallium nitrate and gallium maltolate against Mycobacterium avium subsp. paratuberculosis in vitro

Veterinary Journal

Volumn 202, Issue 1, 2014, Pages 195-197

  Fecteau, Marie Eve ^a   Aceto, Helen W ^a   Bernstein, Lawrence R ^b   Sweeney, Raymond W ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Terrametrix   (United States)

Author keywords

Chemoprophylaxis; Gallium; Johne's disease; Mycobacterium avium subsp. paratuberculosis

Indexed keywords

ANTIINFECTIVE AGENT; GALLIUM MALTOLATE; GALLIUM NITRATE; UNCLASSIFIED DRUG; GALLIUM; ORGANOMETALLIC COMPOUND; PYRONE DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; DOSE RESPONSE; DRUG CONCENTRATION; DRUG EFFICACY; GROWTH INHIBITION; IC90; IC99; IN VITRO STUDY; MYCOBACTERIUM PARATUBERCULOSIS; NONHUMAN; DRUG EFFECTS; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS;

MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS;

ANTI-BACTERIAL AGENTS; GALLIUM; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS; ORGANOMETALLIC COMPOUNDS; PYRONES;

EID: 84912138427     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2014.06.023     Document Type: Article

References (10)

1. Ardito F., Posteraro B., Sanguinetti M., Zanetti S., Fadda G. Evaluation of BACTEC mycobacteria growth indicator tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis. Journal of Clinical Microbiology 2001, 39:4440-4444.
2. Bernstein L.R. Gallium therapeutic effects. Encyclopedia of Metalloproteins 2013, 823-835. Springer, NY, USA. R.H. Kretsinger, V.N. Uversky, E.A. Permyakov (Eds.).
3. Bernstein L.R., Tanner T., Godfrey C., Noll B. Chemistry and pharmacokinetics of gallium maltolate, a compound with high oral gallium bioavailability. Metal-Based Drugs 2000, 7:33-47.
4. Bonchi C., Imperi F., Minandri F., Visca P., Frangipani E. Repurposing of gallium-based drugs for antibacterial therapy. Biofactors (Oxford, England) 2014, 10.1002/biof.1159.
5. Fecteau M.E., Fyock T.L., McAdams S.C., Boston R.C., Whitlock R.H., Sweeney R.W. Evaluation of the in vitro activity of gallium nitrate against Mycobacterium avium subsp paratuberculosis. American Journal of Veterinary Research 2011, 72:1243-1246.
6. Fecteau M.E., Whitlock R.H., Fyock T.L., McAdams S.C., Boston R.C., Sweeney R.W. Antimicrobial activity of gallium nitrate against Mycobacterium avium subsp. paratuberculosis in neonatal calves. Journal of Veterinary Internal Medicine 2011, 25:1152-1155.
7. Heifets L. MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs. Antimicrobial Agents and Chemotherapy 1988, 32:1131-1136.
8. Martens R.J., Mealey K., Cohen N.D., Harrington J.R., Chaffin K., Taylor R.J., Bernstein L.R. Pharmacokinetics of gallium maltolate after intragastric administration in neonatal foals. American Journal of Veterinary Research 2007, 68:1041-1044.
9. Olakamni O., Brittigan B.E., Schlesinger L.S. Gallium disrupts iron metabolism of mycobacteria residing within human macrophages. Infection and Immunity 2000, 68:5619-5627.
10. Sweeney R.W., Whitlock R.H., Bowerstock T.L., Cleary D.L., Meinert T.R., Habecker P.L., Pruitt G.W. Effect of subcutaneous administration of a killed Mycobacterium avium subsp paratuberculosis vaccine on colonization of tissues following oral exposure to the organism in calves. American Journal of Veterinary Research 2009, 70:493-497.